Prometheus is committed to improving lives through the development and commercialization
of novel pharmaceutical and diagnostic products that enable physicians to provide
greater individualized patient care.
New Serum Test Is First to Measure and Monitor Mucosal Healing in Crohn's Disease
New Test Monitors Therapeutic Ustekinumab Levels in IBD Patients
Introducing PROMETHEUS® IBcause™: Convenient All-in-One Diagnostic Test for Persistent Diarrhea
PROMETHEUS® Anser® VDZ Test Validated For Use in Inflammatory Bowel Disease Patients
New Test for Patients Treated ...